Developing new treatments for tuberculosis


Fighting TB, a disease that kills more than 1.5 million people every year


A single product, multiple indications


A GMP Plant to offer specialized services to biotech industry

Archivel Farma is a R&D biotech company that develops immunotherapeutic agents to respond to unmet medical needs


ArchivelPress releaseResearch

Archivel Farma’s RUTI® vaccine to start a clinical trial to increase the immunity of healthcare professionals exposed to the risk of COVID-19

The clinical trial will be carried out at the Germans Trias i Pujol Hospital in Badalona (Can RUTI), and it will include 300 healthy health professionals in direct contact with…

Extension of the authorization for the manufacture of medicines

As of 30th October 2019, Archivel Farma has obtained from the Spanish Health Authority the authorization as Manufacturer for Sterile investigational medicinal products for terminal sterilised operations of Solids and Implants…

Archivel Farma at the annual TBVI meeting

On January 29, Archivel Farma, represented by its CEO, Olga Rúe, and Dr. Pere Joan Cardona, scientific advisor to the company, participated in the annual meeting of the Tuberculosis Vaccine…